WORLD PEPTIDEFOUNDATION

Peptide directory

Find a peptide

Public profiles inside a larger governed registry

Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.

Browse the Master RegistryExplore research atlasesFind studies worldwide

The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.

Published profiles

Search profiles and sources

Compare peptides side by side →
Refine by category
Category

405 peptide records

  • Endogenous copper-binding peptide complex

    GHK-Cu

    Peptide conjugate

    Emerging

    GHK-Cu is the copper(II) complex of the endogenous tripeptide glycyl-L-histidyl-L-lysine. It binds copper and has been studied in copper handling, extracellular-matrix remodeling, fibroblast activity, inflammatory signaling, antioxidant responses, and wound repair. Effects are formulation-, concentration-, route-, and model-dependent.

    Evidence and record details

    Evidence integrity map

    Human 0Preclinical 8Durable IDs 24Open signals 3
    Publication state
    Published profile
    Verified source records
    25 source records verified
    Chemistry record
    Chemistry record on file
    Regulatory entries
    No published regulatory entry on file
    Research questions
    22 open research questions
    Evidence review date
    Documented human review recorded Sep 8, 2026

    Source verification checks records; it does not itself approve scientific conclusions.

    View evidence profile for GHK-Cu

  • Growth hormone secretagogue peptide

    GHRP-2

    Synthetic peptide

    Emerging

    Synthetic growth-hormone secretagogue and ghrelin-receptor agonist studied in endocrine challenge testing.

    Evidence and record details

    Evidence integrity map

    Human 0Preclinical 0Durable IDs 5Open signals 1
    Publication state
    Published profile
    Verified source records
    26 source records verified
    Chemistry record
    Chemistry record on file
    Regulatory entries
    2 published regulatory entries
    Research questions
    No open questions documented
    Evidence review date
    No documented human review recorded

    Source verification checks records; it does not itself approve scientific conclusions.

    View evidence profile for GHRP-2

  • Growth hormone secretagogue peptide

    GHRP-6

    Synthetic peptide

    Emerging

    Synthetic growth-hormone secretagogue and ghrelin-receptor agonist studied in endocrine and metabolic research.

    Evidence and record details

    Evidence integrity map

    Human 0Preclinical 0Durable IDs 4Open signals 3
    Publication state
    Published profile
    Verified source records
    26 source records verified
    Chemistry record
    Chemistry record on file
    Regulatory entries
    2 published regulatory entries
    Research questions
    No open questions documented
    Evidence review date
    No documented human review recorded

    Source verification checks records; it does not itself approve scientific conclusions.

    View evidence profile for GHRP-6

  • Endogenous incretin peptide

    GIP(1-42)

    Published sources available; full evidence profile in development.

    3 published source records. Source publication does not imply scientific appraisal.

    Open sources for GIP(1-42) →

  • Active GLP-1 peptide form

    GLP-1(7-37)

    Published sources available; full evidence profile in development.

    3 published source records. Source publication does not imply scientific appraisal.

    Open sources for GLP-1(7-37) →

  • Endogenous GLP-2 peptide form

    GLP-2(1-33)

    Published sources available; full evidence profile in development.

    1 published source records. Source publication does not imply scientific appraisal.

    Open sources for GLP-2(1-33) →

  • Endogenous peptide hormone

    Glucagon

    Endogenous peptide

    Emerging

    Glucagon is an endogenous peptide hormone central to glucose regulation. The hormone, glucagon-containing medicines, and drugs that target glucagon or GLP-1 pathways answer different biological and clinical questions.

    Evidence and record details

    Evidence integrity map

    Human 0Preclinical 0Durable IDs 6Open signals 1
    Publication state
    Published profile
    Verified source records
    207 source records verified
    Chemistry record
    Chemistry record on file
    Regulatory entries
    2 published regulatory entries
    Research questions
    No open questions documented
    Evidence review date
    No documented human review recorded

    Source verification checks records; it does not itself approve scientific conclusions.

    View evidence profile for Glucagon

  • GnRH agonist

    Goserelin

    Published sources available; full evidence profile in development.

    1 published source records. Source publication does not imply scientific appraisal.

    Open sources for Goserelin →
How the public directory relates to the 500-record Master Registry

master registry transparency

500 master records, with governance status shown explicitly

WPF-MASTER-REGISTRY-TRANSPARENCY-1.0
501
Master records
467
Governed records
34
Review-deferred
458
Peptide acquisition eligible
9
Governed comparators

The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the source acquisition cohort. Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.

Explore the full Master Registry →
What the profile status labels mean

Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.

Recently updated public records

When each public profile record was last changed — not clinical or scientific activity.

Peptide Directory — World Peptide Foundation